ROCHESTER, MI--(Marketwired - November 13, 2014) - OPTIMIZERx Corp. (OTCQB: OPRX) announced today its financial results for the quarter and nine month periods ended September 30, 2014. The Company reported total revenues of approximately $4.4 million for the nine month period, an
ROCHESTER, MI--(Marketwired - November 06, 2014) - OPTIMIZERx Corp. (OTCQB: OPRX) announced that it will hold its Q3 2014 earnings call on Thursday, November 13, 2014 at 11:30 am Eastern Time. The call details are: Toll-Free Dial-In Number: 1 (866) 593-0056 or toll: +1 (937) 641-0555
Starts Coverage With Buy Rating and $4.00 Price Target ROCHESTER, MI--(Marketwired - October 29, 2014) - OptimizeRx Corporation (OTCQB: OPRX) announced that Noble Financial Capital Markets recently initiated coverage on OptimizeRx Corporation with a buy rating and stock target of
ROCHESTER, MI--(Marketwired - September 23, 2014) - OPTIMIZERx Corporation (OTCQB: OPRX) announced today that it is sponsoring the CBInet EHR Pharmaceutical Industry Conference October 1, 2014 at the Hyatt Regency at Penn's Landing, Philadelphia PA.
ROCHESTER, MI--(Marketwired - August 15, 2014) - OPTIMIZERx Corp. (OTCQB: OPRX) announced today its financial results for the quarter and six month periods ended June 30, 2014. The Company reported total revenues of approximately $2.75 million for the six month period, an increase of
ROCHESTER, MI--(Marketwired - August 14, 2014) - OPTIMIZERx Corp. (OTCQB: OPRX) announced today that Dr. Jack Pinney has joined its Board of Directors. Dr. Pinney is a Board-certified Family Physician with additional board certification in Sports Medicine. He is also an
ROCHESTER, MI--(Marketwired - August 12, 2014) - OPTIMIZERx Corp. (OTCQB: OPRX) announced that it will hold its Q2 2014 earnings call on Friday, August 15, 2014 at 12:00 pm Eastern Time. The call details are: Toll-Free Dial-In Number: 1(866) 593-0056 or toll: +1(937) 641-0554 Provide
ROCHESTER, MI--(Marketwired - August 11, 2014) - OPTIMIZERx Corporation (OTCQB: OPRX) announced today that Gus D. Halas has joined its Board of Directors. Mr. Halas has an extensive operating background at a variety of companies across a wide range of industries. Mr.
ROCHESTER, Mich., July 23, 2014 /PRNewswire/ -- OPTIMIZERx Corporation (OTCQB: OPRX) announced key updates and commented on San Francisco-based Merriman Capital's recently initiated coverage on OptimizeRx Corporation with a buy rating and stock target of $3.00.
ROCHESTER, MI--(Marketwired - May 16, 2014) - OPTIMIZERx Corp. (OTCQB: OPRX) announced that it finished the first quarter for 2014 with revenues of $1,317,347 which is a 97% increase over the same first quarter period in 2013, and the organization generated positive net cash of $226,727 from
